<DOC>
	<DOCNO>NCT01749085</DOCNO>
	<brief_summary>The study aim determine effect high fat meal drug exposure PF-04449913 . The study also aim determine effect strong enzyme ( CYP3A4 ) inhibitor drug exposure PF-04449913 .</brief_summary>
	<brief_title>Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Healthy male female subject age 18 55 year ( inclusive ) : Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . An informed consent document sign date subject . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . A positive urine drug screen 12lead ECG demonstrate QTc &gt; 450 msec QRS interval &gt; 120 msec Screening . If QTc exceed 450 msec , QRS exceed 120 msec , ECG repeat two time average three QTc value use determine subject 's eligibility . Subjects one follow currently past 6 month : myocardial infarction , congenital long QT syndrome , torsades de pointes clinically significant ventricular arrhythmia . Pregnant nursing female females childbearing potential include tubal ligation . To consider enrollment , woman 45 55 year age postmenopausal ( define amenorrheic least 2 year ) must confirmatory FSH test result Screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>PF-04449913</keyword>
	<keyword>Food Effect</keyword>
	<keyword>Drug-drug interaction</keyword>
	<keyword>CYP3A4 inhibitor</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>